PXT3003

· Tasly GeneNet Pharmaceuticals Co., Ltd

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PXT3003, covering 2020-02-27 to 2025-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Efficacy and Safety of PXT3003 in Charcot-Marie-Tooth Type 1A [Phase 3]